SETD2 and cancer: Towards this end, we targeted the transcription factor nuclear factor-kappaB (NF-κB), which is activated in cancers and regulates inflammation-associated epigenetic changes.21, 22 Using pharmacological and genomic approaches, we show upregulation of NSD1 and SETD2 upon NF-κB inhibition.